Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Journal:

Nature Communications

Published:

2025-10-06

DOI:

10.1038/s41467-025-63948-4

Affiliations:

74

Authors:

108

Go to article

Institutions	Authors	Share
Fred Hutchinson Cancer Center, United States of America (USA)	18.000000 18.000000	0.17
Duke University, United States of America (USA)	11.000000 11.000000	0.10
University of Cape Town (UCT), South Africa	5.083333	0.05
University of the Witwatersrand, Johannesburg (Wits University), South Africa	3.916667	0.04
Desmond Tutu Health Foundation (DTHF), South Africa	3.750000	0.03
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	3.000000	0.03
The Aurum Institute, South Africa	3.000000	0.03
South African Medical Research Council (SAMRC), South Africa	3.000000	0.03
Merclinco, South Africa	3.000000	0.03
University of Washington (UW), United States of America (USA)	2.500000	0.02
Centre for the AIDS Programme of Research in South Africa (CAPRISA), South Africa	2.500000	0.02
Baylor College of Medicine Children’s Foundation - Uganda (Baylor - Uganda), Uganda	2.000000	0.02
University of Zimbabwe (UZ), Zimbabwe	2.000000	0.02
Centre for Infectious Diseases Research in Zambia (CIDRZ), Zambia	2.000000	0.02
Synexus Helderberg Clinical Research Centre, South Africa	2.000000	0.02
TASK, South Africa	2.000000	0.02
Zambia-Emory HIV Research Project (ZEHRP), Zambia	2.000000	0.02
Soweto Clinical Trials Centre, South Africa	2.000000	0.02
Kenya Medical Research Institute (KEMRI), Kenya	2.000000	0.02
Walter Sisulu University (WSU), South Africa	2.000000	0.02
UVRI-IAVI HIV Vaccine Program, Uganda	2.000000	0.02
National Health Laboratory Service (NHLS), South Africa	1.916667	0.02
SAMRC/NICD Antibody Immunity Research Unit, South Africa	1.916667	0.02
Cape Town HVTN Immunology Laboratory (CHIL) / Hutchinson Centre Research Institute of South Africa, South Africa	1.833333	0.02
Johns Hopkins Research Project - Malawi, Malawi	1.500000	0.01
Chris Hani Baragwanath Hospital, South Africa	1.333333	0.01
University of Pennsylvania (Penn), United States of America (USA)	1.000000	0.01
New York University (NYU), United States of America (USA)	1.000000	0.01
Botswana Harvard AIDS Institute Partnership (BHP), Botswana	1.000000	0.01
Helen Joseph Hospital, South Africa	1.000000	0.01
Stellenbosch University (SU), South Africa	1.000000	0.01
Josha Research, South Africa	1.000000	0.01
UNC -Zambia, Zambia	1.000000	0.01
Synergy Biomed Research Institute (SBRI), South Africa	1.000000	0.01
Newtown Clinical Research Centre, South Africa	1.000000	0.01
MRC/Wits Developmental Pathways for Health Research Unit (DPHRU), South Africa	1.000000	0.01
Joint Clinical Research Centre (JCRC), Uganda	1.000000	0.01
Sefako Makgatho Health Sciences University (SMU), South Africa	1.000000	0.01
Phoenix Pharma, South Africa	1.000000	0.01
Moi University, Kenya	1.000000	0.01
MU-JHU Research Collaboration Clinical Research Site, Uganda	1.000000	0.01
Qhakaza Mbokodo Research Clinic, South Africa	1.000000	0.01
University of KwaZulu-Natal (UKZN), South Africa	0.750000	0.01
Centre for Epidemic Response and Innovation (CERI), South Africa	0.500000	0.00
ICAP at Columbia University - Eswatini, Eswatini	0.500000	0.00
Columbia University Mailman School of Public Health, United States of America (USA)	0.500000	0.00
UNC Project-Malawi (UNC Project), Malawi	0.500000	0.00
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	0.500000	0.00
Kamuzu University of Health Sciences (KUHeS), Malawi	0.500000	0.00
US Army Medical Research Directorate-Kenya (USAMRU-Kenya), Kenya	0.500000	0.00
Maseno University, Kenya	0.500000	0.00

Interested in Immunology?